Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (FY)Feb 29, 2024 | (FY)Feb 28, 2023 | |
|---|---|---|---|
| Operating cash flow (Indirect Method) | |||
| Cash from operating activities | 13.64%2.13B | 84.60%1.88B | 1.02B |
| Net profit before non-cash adjustment | 2.35%1.58B | 241.24%1.54B | --451.34M |
| Total adjustment of non-cash items | 87.42%698.33M | 63.18%372.6M | --228.33M |
| -Depreciation and amortization | 15.64%482.26M | 18.66%417.04M | --351.46M |
| -Reversal of impairment losses recognized in profit and loss | 1,245.01%160.41M | -91.48%11.93M | --140.02M |
| -Disposal profit | -89.93%3.64M | 97.88%36.1M | --18.24M |
| -Other non-cash items | 156.27%52.03M | 67.14%-92.47M | ---281.39M |
| Changes in working capital | -292.07%-142.18M | -110.77%-36.27M | --336.83M |
| -Change in receivables | 42.14%-104.29M | -27.14%-180.26M | ---141.78M |
| -Change in inventory | -346.76%-7.47M | 125.57%3.03M | ---11.83M |
| -Change in payables | -76.11%25.38M | -75.93%106.23M | --441.24M |
| -Provision for loans, leases and other losses | -95.98%2.36M | 309.93%58.66M | --14.31M |
| -Changes in other current assets | -179.54%-72.68M | -117.68%-26M | ---11.94M |
| -Changes in other current liabilities | 598.27%14.52M | -95.56%2.08M | --46.84M |
| Dividends paid (cash flow from operating activities) | |||
| Dividends received (cash flow from operating activities) | |||
| Interest paid (cash flow from operating activities) | -6.59%-64.04M | -20.56%-60.08M | -49.84M |
| Interest received (cash flow from operating activities) | 545.33%5.45M | 21.93%845K | 693K |
| Tax refund paid | -331.08%-658.57M | 64.65%-152.77M | -432.13M |
| Other operating cash inflow (outflow) | -97.48%3.38M | -81.72%133.97M | 732.69M |
| Operating cash flow | -21.11%1.42B | 41.84%1.8B | --1.27B |
| Investing cash flow | |||
| Net PPE purchase and sale | -70.95%-702.58M | -38.90%-410.99M | ---295.89M |
| Net intangibles purchase and sale | --0 | 36.52%-2.26M | ---3.56M |
| Net investment product transactions | 24.79%-73.82M | -82.21%-98.16M | ---53.87M |
| Net changes in other investments | 46.52%-42.78M | -139.88%-80M | ---33.35M |
| Investing cash flow | -38.52%-819.18M | -52.95%-591.4M | ---386.67M |
| Financing cash flow | |||
| Net issuance payments of debt | -166.14%-763.43M | 680.18%1.15B | --147.95M |
| Net common stock issuance | --4.74B | ---- | ---- |
| Increase or decrease of lease financing | -10.08%-90.16M | -98.09%-81.91M | ---41.35M |
| Cash dividends paid | ---320M | ---- | ---- |
| Net other fund-raising expenses | ---- | ---- | ---1K |
| Financing cash flow | 232.28%3.56B | 905.95%1.07B | --106.61M |
| Net cash flow | |||
| Beginning cash position | 54.05%6.5B | 30.59%4.22B | --3.23B |
| Current changes in cash | 82.63%4.16B | 130.75%2.28B | --987.86M |
| Cash adjustments other than cash changes | ---- | --1K | ---- |
| End cash Position | 64.07%10.66B | 54.05%6.5B | --4.22B |
| Free cash flow | -48.49%711.19M | 43.60%1.38B | --961.48M |
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |